(MENAFN- PR Newswire)
EXTON, Pa., Oct. 7, 2024
/PRNewswire/ -- West Pharmaceutical Services, Inc.
(NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challenges and trends in packaging and containment.
This year, West will highlight its industry expertise through a technical-focused presentation:
Examining Contamination Control Strategy in Primary Packaging as part of
EU GMP Annex 1- Wednesday, October 9 | 2:15 - 2:40 p.m.
Presented by Ana
Kuschel, Principal, Scientific Affairs, West
"The revisions to EU GMP Annex 1 represent a significant shift in drug manufacturing with over 30 references to primary packaging alone," said Cindy Reiss-Clark, Chief Commercial Officer at West.
"At West, we know a drug manufacturer's contamination control strategy is only as strong as its weakest link, making the quality and control of materials from third party suppliers' critical factors to their process."
West is also a finalist for a
CPHI Award
in the "Heart of Pharma" category for its partnership with Fox Chase Cancer Center.
This award recognizes companies, individuals and initiatives which nurture philanthropic, ethical and community-based ventures. Winners will be announced during the awards ceremony on the opening night of CPHI on October 8.
For more information about West, please visit our website: .
For more information about CPHI
Worldwide , please visit:
CPHI Milan
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & Poor's 500 index. For more information, visit .
SOURCE West Pharmaceutical Services, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
MENAFN07102024003732001241ID1108752485
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.